Medpace Holdings, Inc.·4

Oct 29, 5:12 PM ET

GEIGER JESSE J 4

4 · Medpace Holdings, Inc. · Filed Oct 29, 2025

Insider Transaction Report

Form 4
Period: 2025-10-27
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-27$166.73/sh+19,460$3,244,56655,963 total
  • Sale

    Common Stock

    2025-10-29$585.00/sh3,568$2,087,28036,503 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-10-293,5680 total
    Exercise: $166.73Exp: 2026-10-27Common Stock (3,568 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-10-2719,4603,568 total
    Exercise: $166.73Exp: 2026-10-27Common Stock (19,460 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-29$166.73/sh+3,568$594,89340,071 total
  • Sale

    Common Stock

    2025-10-27$605.12/sh19,460$11,775,63536,503 total
Footnotes (3)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
  • [F2]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.00 to $610.66. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
  • [F3]The option vested in full on October 27, 2025.

Documents

1 file
  • 4
    wk-form4_1761772348.xmlPrimary

    FORM 4